Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-13

Clinical Trial Update: Calcium Electroporation as a Treatment for Cutaneous and Subcutaneous Malignant Tumours [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating calcium electroporation as a treatment for cutaneous and subcutaneous malignant tumours.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium electroporation (calcium electroporation)

Snippet

Sponsor: Zealand University Hospital | Conditions: Cancer | Phase 2 | Status: UNKNOWN